Risks of old, new diet drugs face U.S. scrutiny
WASHINGTON (Reuters) - The risks of a potential new diet pill and a 13-year-old weight-loss medicine face U.S. scrutiny next week as medical experts consider if the drugs' benefits outweigh possible side effects.
10 September 2010 - Share
USDA knew of problems at farm behind egg recall: report
BANGALORE (Reuters) - U.S. Department of Agriculture experts knew about sanitary problems at one of the two Iowa farms at the center of a massive nationwide egg recall, but did not notify health authorities, the Wall Street Journal reported.
10 September 2010 - Share
FDA cracks down on 5 makers of e-cigarettes
CHICAGO (Reuters) - The U.S. Food and Drug Administration sent warnings to five makers of electronic cigarettes for marketing them illegally as stop-smoking aids and said on Thursday it intends to regulate the products as drugs.
10 September 2010 - Share
Study backs prostate screening for high risk men
LONDON (Reuters) - Men who have a certain genetic variations that put them at higher risk of prostate cancer may benefit from regular screening for the disease, a study by British scientists found Friday.
10 September 2010 - Share
Risks of old, new diet drugs face U.S. scrutiny
WASHINGTON (Reuters) - The risks of a potential new diet pill and a 13-year-old weight-loss medicine face U.S. scrutiny next week as medical experts consider if the drugs' benefits outweigh possible side effects.
09 September 2010 - Share
UK's NICE wants more data on schizophrenia drug
LONDON (Reuters) - Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness.
10 September 2010 - Share
FDA cracks down on 5 makers of e-cigarettes
CHICAGO (Reuters) - The U.S. Food and Drug Administration sent warnings to five makers of electronic cigarettes for marketing them illegally as stop-smoking aids and said on Thursday it intends to regulate the products as drugs.
09 September 2010 - Share
UK's NICE wants more data on BMS schizophrenia drug
LONDON (Reuters) - Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness.
09 September 2010 - Share
J&J widens access as cancer drug helps survival
NEW YORK (Reuters) - All patients in a study of a Johnson & Johnson drug for advanced prostate cancer will be offered the medicine after an independent monitoring committee found it demonstrated an improvement in patient survival.
09 September 2010 - Share
Do kids, men need folic acid from a pill?
NEW YORK (Reuters Health) - With the advent of folic-acid supplementation of certain foods, few Canadians are now getting too little of the B vitamin, a new study estimates -- in findings that question the need for children and men to get additional folic acid from vitamins.
09 September 2010 - Share
